Quinethazone, marketed as Hydromox, is a thiazide diuretic indicated for hypertension. Patients may experience adverse reactions such as dizziness, dry mouth, nausea, and hypokalemia.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Nicotine | The risk or severity of adverse effects can be increased when Quinethazone is combined with Nicotine. |
| Mecamylamine | The risk or severity of adverse effects can be increased when Quinethazone is combined with Mecamylamine. |
| Pentolinium | The risk or severity of adverse effects can be increased when Quinethazone is combined with Pentolinium. |
| Trimethaphan | The risk or severity of adverse effects can be increased when Quinethazone is combined with Trimethaphan. |
| Hexamethonium | The risk or severity of adverse effects can be increased when Quinethazone is combined with Hexamethonium. |
| Cyclopentamine | The risk or severity of adverse effects can be increased when Quinethazone is combined with Cyclopentamine. |
| Allopurinol | The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Quinethazone. |
| Carbamazepine | The risk or severity of adverse effects can be increased when Quinethazone is combined with Carbamazepine. |
| Cyclophosphamide | The risk or severity of granulocytopenia can be increased when Quinethazone is combined with Cyclophosphamide. |
| Diazoxide | The risk or severity of hypotension, hyperglycemia, and hyperuricemia can be increased when Quinethazone is combined with Diazoxide. |
| Dofetilide | The risk or severity of QTc prolongation can be increased when Quinethazone is combined with Dofetilide. |
| Ivabradine | The risk or severity of Cardiac Arrhythmia can be increased when Quinethazone is combined with Ivabradine. |
| Lithium citrate | Quinethazone may decrease the excretion rate of Lithium citrate which could result in a higher serum level. |
| Lithium carbonate | Quinethazone may decrease the excretion rate of Lithium carbonate which could result in a higher serum level. |
| Lithium hydroxide | Quinethazone may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level. |
| Oxcarbazepine | The risk or severity of hyponatremia can be increased when Quinethazone is combined with Oxcarbazepine. |
| Topiramate | The risk or severity of hypokalemia can be increased when Quinethazone is combined with Topiramate. |
| Toremifene | The risk or severity of hypercalcemia can be increased when Quinethazone is combined with Toremifene. |
| Methotrexate | The protein binding of Methotrexate can be increased when combined with Quinethazone. |
| Sulpiride | The risk or severity of orthostatic hypotension can be increased when Quinethazone is combined with Sulpiride. |
| Insulin human | The risk or severity of hypoglycemia can be increased when Quinethazone is combined with Insulin human. |
| Insulin lispro | The risk or severity of hypoglycemia can be increased when Quinethazone is combined with Insulin lispro. |
| Insulin glargine | The risk or severity of hypoglycemia can be increased when Quinethazone is combined with Insulin glargine. |
| Insulin pork | The risk or severity of hypoglycemia can be increased when Quinethazone is combined with Insulin pork. |
| Troglitazone | The therapeutic efficacy of Troglitazone can be decreased when used in combination with Quinethazone. |
| Glimepiride | The therapeutic efficacy of Glimepiride can be decreased when used in combination with Quinethazone. |
| Sulfisoxazole | The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Quinethazone. |
| Disopyramide | The therapeutic efficacy of Disopyramide can be decreased when used in combination with Quinethazone. |
| Acarbose | The therapeutic efficacy of Acarbose can be decreased when used in combination with Quinethazone. |
| Metformin | The therapeutic efficacy of Metformin can be decreased when used in combination with Quinethazone. |
| Sulfadiazine | The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Quinethazone. |
| Rosiglitazone | The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Quinethazone. |
| Acetohexamide | The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Quinethazone. |
| Quinine | The therapeutic efficacy of Quinine can be decreased when used in combination with Quinethazone. |
| Miglitol | The therapeutic efficacy of Miglitol can be decreased when used in combination with Quinethazone. |
| Chlorpropamide | The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Quinethazone. |
| Nateglinide | The therapeutic efficacy of Nateglinide can be decreased when used in combination with Quinethazone. |
| Pentamidine | The therapeutic efficacy of Pentamidine can be decreased when used in combination with Quinethazone. |
| Mifepristone | The therapeutic efficacy of Mifepristone can be decreased when used in combination with Quinethazone. |
| Tolazamide | The therapeutic efficacy of Tolazamide can be decreased when used in combination with Quinethazone. |
| Repaglinide | The therapeutic efficacy of Repaglinide can be decreased when used in combination with Quinethazone. |
| Phenformin | The therapeutic efficacy of Phenformin can be decreased when used in combination with Quinethazone. |
| Sulfamethoxazole | The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Quinethazone. |
| Glyburide | The therapeutic efficacy of Glyburide can be decreased when used in combination with Quinethazone. |
| Glipizide | The therapeutic efficacy of Glipizide can be decreased when used in combination with Quinethazone. |
| Gliclazide | The therapeutic efficacy of Gliclazide can be decreased when used in combination with Quinethazone. |
| Tolbutamide | The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Quinethazone. |
| Pioglitazone | The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Quinethazone. |
| Bromocriptine | The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Quinethazone. |
| Gliquidone | The therapeutic efficacy of Gliquidone can be decreased when used in combination with Quinethazone. |
| Mitiglinide | The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Quinethazone. |
| Sitagliptin | The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Quinethazone. |
| Sunitinib | The therapeutic efficacy of Sunitinib can be decreased when used in combination with Quinethazone. |
| Exenatide | The therapeutic efficacy of Exenatide can be decreased when used in combination with Quinethazone. |
| Mecasermin | The therapeutic efficacy of Mecasermin can be decreased when used in combination with Quinethazone. |
| Pramlintide | The therapeutic efficacy of Pramlintide can be decreased when used in combination with Quinethazone. |
| Glisoxepide | The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Quinethazone. |
| Insulin aspart | The risk or severity of hypoglycemia can be increased when Quinethazone is combined with Insulin aspart. |
| Insulin detemir | The risk or severity of hypoglycemia can be increased when Quinethazone is combined with Insulin detemir. |
| Insulin glulisine | The risk or severity of hypoglycemia can be increased when Quinethazone is combined with Insulin glulisine. |
| Glymidine | The therapeutic efficacy of Glymidine can be decreased when used in combination with Quinethazone. |
| AICA ribonucleotide | The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with Quinethazone. |
| Buformin | The therapeutic efficacy of Buformin can be decreased when used in combination with Quinethazone. |
| Vildagliptin | The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Quinethazone. |
| Voglibose | The therapeutic efficacy of Voglibose can be decreased when used in combination with Quinethazone. |
| NN344 | The risk or severity of hypoglycemia can be increased when Quinethazone is combined with NN344. |
| AMG-222 | The therapeutic efficacy of AMG-222 can be decreased when used in combination with Quinethazone. |
| Bisegliptin | The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Quinethazone. |
| Alogliptin | The therapeutic efficacy of Alogliptin can be decreased when used in combination with Quinethazone. |
| Dapagliflozin | The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Quinethazone. |
| Saxagliptin | The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Quinethazone. |
| Liraglutide | The therapeutic efficacy of Liraglutide can be decreased when used in combination with Quinethazone. |
| Gosogliptin | The therapeutic efficacy of Gosogliptin can be decreased when used in combination with Quinethazone. |
| Linagliptin | The therapeutic efficacy of Linagliptin can be decreased when used in combination with Quinethazone. |
| Canagliflozin | The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Quinethazone. |
| Glibornuride | The therapeutic efficacy of Glibornuride can be decreased when used in combination with Quinethazone. |
| Benfluorex | The therapeutic efficacy of Benfluorex can be decreased when used in combination with Quinethazone. |
| Albiglutide | The therapeutic efficacy of Albiglutide can be decreased when used in combination with Quinethazone. |
| Dulaglutide | The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Quinethazone. |
| Lobeglitazone | The therapeutic efficacy of Lobeglitazone can be decreased when used in combination with Quinethazone. |
| Netoglitazone | The therapeutic efficacy of Netoglitazone can be decreased when used in combination with Quinethazone. |
| Rivoglitazone | The therapeutic efficacy of Rivoglitazone can be decreased when used in combination with Quinethazone. |
| Ciglitazone | The therapeutic efficacy of Ciglitazone can be decreased when used in combination with Quinethazone. |
| Lixisenatide | The therapeutic efficacy of Lixisenatide can be decreased when used in combination with Quinethazone. |
| Insulin beef | The risk or severity of hypoglycemia can be increased when Quinethazone is combined with Insulin beef. |
| Insulin degludec | The risk or severity of hypoglycemia can be increased when Quinethazone is combined with Insulin degludec. |
| Insulin peglispro | The risk or severity of hypoglycemia can be increased when Quinethazone is combined with Insulin peglispro. |
| Insulin tregopil | The risk or severity of hypoglycemia can be increased when Quinethazone is combined with Insulin tregopil. |
| Ipragliflozin | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Quinethazone. |
| Dutogliptin | The therapeutic efficacy of Dutogliptin can be decreased when used in combination with Quinethazone. |
| Allicin | The therapeutic efficacy of Allicin can be decreased when used in combination with Quinethazone. |
| Tofogliflozin | The therapeutic efficacy of Tofogliflozin can be decreased when used in combination with Quinethazone. |
| Ertugliflozin | The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Quinethazone. |
| 2,4-thiazolidinedione | The therapeutic efficacy of 2,4-thiazolidinedione can be decreased when used in combination with Quinethazone. |
| Teneligliptin | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Quinethazone. |
| Omarigliptin | The therapeutic efficacy of Omarigliptin can be decreased when used in combination with Quinethazone. |
| Carmegliptin | The therapeutic efficacy of Carmegliptin can be decreased when used in combination with Quinethazone. |
| Gemigliptin | The therapeutic efficacy of Gemigliptin can be decreased when used in combination with Quinethazone. |
| Anagliptin | The therapeutic efficacy of Anagliptin can be decreased when used in combination with Quinethazone. |
| Evogliptin | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Quinethazone. |